Page 44 - 83_01
P. 44
Trichomonas vaginalis: The versatility of a tenacious parasite females and males. J Clin Microbiol 2003; 41: 5619-
22.
Trichomonas vaginalis genital infections: progress
and challenges. Clin Infect Dis 2011; 53: S160-72. 176. Pillay A, Lewis J, Ballard RC. Evaluation of
Xenostrip-Tv, a rapid diagnostic test for Trichomonas
163. Gimenes F, Souza RP, Bento JC, et al. Male vaginalis infection. J Clin Microbiol 2004; 42: 3853-
infertility: a public health issue caused by sexually 6.
transmitted pathogens. Nat Rev Urol 2014; 11; 672-
687. 177. Hobbs MM, Kazembe P, Reed AW, et al.
Trichomonas vaginalis as a cause of urethritis in
164. Lee JJ, Moon HS, Lee TC, Hwang HS, Ahn M-H, Malawian men. Sex Transm Dis 1999; 26: 381-7.
Ryu J-S. PCR for diagnosis of male Trichomonas
vaginalis infection with chronic prostatitis and 178. Jones HE, Lippman SA, Caiaffa-Filho HH, Young T,
urethritis. Korean J Parasitol 2012; 50: 157-9. van de Wijgert JH. Performance of a rapid self-test for
detection of Trichomonas vaginalis in South Africa
164. Pillay DG, Hoosen AA, Vezi B, Moodley C. and Brazil. J Clin Microbiol 2013 ; 51: 1037-9.
Diagnosis of Trichomonas vaginalis in male urethritis.
Trop Geogr Med 1994; 46: 44-5. 179. Durel P, Roiron V, Siboulet A, Borel LJ. Systemic
treatment of human trichomoniasis with a derivative
165. Huppert JS, Batteiger BE, Braslins P, et al. Use of an of nitro-imidazole, 8823 RP. Br J Venereal Dis 1960;
immunochromatographic assay for rapid detection of 36: 21-6.
Trichomonas vaginalis in vaginal specimens. J Clin
Microbiol 2005; 43: 684-7. 180. Vázquez F, García MJ, Pérez F, Palacio V.
Trichomonas vaginalis: treatment and resistance to
166. Hegazy MM, El-Tantawy NL, Soliman MM, El- nitroimidazoles. Enferm Infecc Microbiol Clin 2001;
Sadeek ES, El-Nagar HS. Performance of rapid 19: 114-24.
immunochromatographic assay in the diagnosis of
Trichomoniasis vaginalis. Diagn Microbiol Infect Dis 181. Moreno SN, Docampo R. Mechanism of toxicity of
2012; 74: 49-53. nitro compounds used in the chemotherapy of
trichomoniasis. Environ Health Persp 1985; 64: 199-
167. Workowski KA, Berman S. Sexually transmitted 208.
diseases treatment guidelines, 2010. MMWR Recomm
Rep 2010; 59: 1-110. 182. Bendesky A, Menendez D, Ostrosky-Wegman P. Is
metronidazole carcinogenic? Mutat Res 2002; 511:
169. Carney JA, Unadkat P, Yule A, Rajakumar R, Lacey 133-44.
CJ, Ackers JP. New rapid latex agglutination test for
diagnosing Trichomonas vaginalis infection. J Clin 183. WHO. The selection and use of essential medicines
Pathol 1988; 41: 806-8. Report of the WHO Expert Committee, 2006; pp. 933.
170. Alderete JF, Neace CJ. Identification, 184. OMS. Guías para el tratamiento de las infecciones de
characterization, and synthesis of peptide epitopes and transmisión sexual. 2005; Organización Mundial de la
a recombinant six-epitope protein for Trichomonas Salud.
vaginalis serodiagnosis. J Immuno Targets Ther 2013;
2: 91-103. 185. Gatski M, Kissinger P. Observation of probable
persistent, undetected Trichomonas vaginalis infection
171. Huppert JS, Mortensen JE, Reed JL, et al. Rapid among HIV-positive women. Clin Infect Dis 2010;
antigen testing compares favorably with transcription- 51: 114-5.
mediated amplification assay for the detection of
Trichomonas vaginalis in young women. Clin Infect 186. Kissinger P, Secor WE, Leichliter JS, et al. Early
Dis 2007; 45: 194-8. repeated infections with Trichomonas vaginalis
among HIV-positive and HIV-negative women. Clin
172. Nye MB, Schwebke JR, Body BA. Comparison of Infect Dis 2008; 46: 994-9.
APTIMA Trichomonas vaginalis transcription-
mediated amplification to wet mount microscopy, 187. Kissinger P, Adamski A. Trichomoniasis and HIV
culture, and polymerase chain reaction for diagnosis interactions: a review. Sex Transm Infect 2013; 89:
of trichomoniasis in men and women. Am J Obstet 426-33.
Gynecol 2009; 200: 188-195.
188. Van Der Pol B, Williams JA, Orr DP, Batteiger BE,
173. Soper D. Trichomoniasis: Under control or Fortenberry JD. Prevalence, incidence, natural history,
undercontrolled? Am J Obstet Gynecol 2004; 190: and response to treatment of Trichomonas vaginalis
281-290. infection among adolescent women. J Infect Dis 2006;
192: 2039-44.
174. Andrea SB, Chapin KC. Comparison of Aptima
Trichomonas vaginalis transcription-mediated 190. Karhunen M. Placental transfer of metronidazole and
amplification assay and BD affirm VPIII for detection tinidazole in early human pregnancy after a single
of T. vaginalis in symptomatic women: performance infusion. Br J Clin Pharmacol 1984; 18: 254-7.
parameters and epidemiological implications. J Clin
Microbiol 2011; 49: 866-9. 191. Erickson SH, Oppenheim GL, Smith GH.
Metronidazole in breast milk. Obstet Gynecol 1981;
175. Hardick J, Yang S, Lin S, Duncan D, Gaydos C. Use 57: 48-50.
of the Roche LightCycler instrument in a real-time
PCR for Trichomonas vaginalis in urine samples from 192. Knox RJ, Knight RC, Edwards DI. Interaction of
@Real Academia Nacional de Farmacia. Spain 45
